Editorial commentary: The long road toward standardization of viral load testing for cytomegalovirus

Clinical Infectious Diseases

Volumn 56, Issue 3, 2013, Pages 374-375

  Caliendo, Angela M ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; REAGENT; VIRUS DNA;

ANTIVIRAL RESISTANCE; CALIBRATION; CLINICAL DECISION MAKING; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS DNA TEST; DNA DETERMINATION; FOOD AND DRUG ADMINISTRATION; GRAFT RECIPIENT; HEPATITIS C VIRUS; HUMAN; INFECTION; LABORATORY DEVELOPED TEST; LABORATORY TEST; MOLECULAR DIAGNOSTICS; MULTICENTER STUDY (TOPIC); NOTE; PATIENT CARE; PREDICTIVE VALUE; PRIORITY JOURNAL; RELAPSE; TREATMENT RESPONSE; VIRUS LOAD; WORKFLOW; WORLD HEALTH ORGANIZATION; CYTOMEGALOVIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; STANDARD;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84872304119     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis905     Document Type: Note

References (11)

1. Humar A, Gregson D, Caliendo AM, et al. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 1999; 68:1305.
2. Emery VC, Sabin CA, Cope AV, et al. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000; 355:2032.
3. Sia IG, Wilson JA, Groettum CM, et al. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation. J Infect Dis 2000; 181:717.
4. Caliendo AM, St George K, Kao SY, et al. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. J Clin Microbiol 2000; 38:2122.
5. Humar A, Kumar D, Boivin G, Caliendo AM. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solidorgan transplant patients with CMV disease. J Infect Dis 2002; 186:829.
6. Kotton CN, Kumar D, Caliendo AM, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2101; 89:779.
7. Preiksaitis JK, Brennan DC, Fishman J, Allen U. Canadian Society of Transplantation Consensus Workshop on Cytomegalovirus Management in Solid Organ Transplantation final report. Am J Transplant 2005; 5:218-27.
8. Andrews PA, Emery VC, Newstead C. Summary of British Transplantation Society guidelines for the prevention and management of CMV disease after solid organ trnasplantation. Transplantation 2011; 92: 1181-7.\
9. Pang XL, Fox JD, Fenton JM, et al. Interlaboratory comparison of cytomegalovirus viral load assays. Am J Transplant 2009; 9:258.
10. Hayden RT, Yan X, Wick MT, et al. Factors contributing to the variability of quantitative viral PCR results in proficiency testing samples: a multivariate analysis. J Clin Microbiol 2012; 50:337-45.
11. Hirsch HH, Lautenschlager I, Pinsky BA, et al. An international multicenter performance analysis of cytomegalovirus load tests. Clin Infect Dis 2013; 56:367-73.